Expansion of services related to healthcare big data
First written in FY2017-Q1. 20 of 39 entries say "Advanced", first in FY2018-Q1. Latest entry: 2026-08-13.
7 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Revenue was ¥3,503 million, up 11.2% year on year, and operating profit was ¥886 million, up 33.9% year on year. The main factors were revenue growth in data utilization services, claims review services, and cloud-based claims management services for public assistance, among others, as well as improved profitability at 株式会社ケーシップ, which joined this business in the previous fiscal year.」
Revenue increased in data utilization, claims review, and cloud services for public assistance, among others, while improved profitability at ケーシップ also contributed. The healthcare big data business delivered 11.2% revenue growth and 33.9% operating profit growth. - FY2026-H1AdvancedAnnual report
「The main factors were revenue growth in the claims review service, data utilization service, and cloud-based claims management service for public assistance, among others, as well as improved profitability at 株式会社ケーシップ, which joined this business in the previous fiscal year.」
Revenue increased in claims review, data utilization, and cloud-based claims management for public assistance, among others, while improved profitability at ケーシップ also contributed. The healthcare big data business delivered 10.2% revenue growth and 150.8% operating profit growth. - FY2025Full-year revenue growth, but a slight decline in profit due to strategic investmentAnnual report
「Revenue was ¥3,150 million, up 19.2% year on year, and operating profit was ¥662 million, down 3.5% year on year. The main factor was revenue growth driven by strong performance in claims review and analysis services, among others, while higher costs aimed at medium- to long-term growth, including the addition of 株式会社ケーシップ to this business, resulted in a slight decline in profit. Results for the business finished within the range of the initial plan.」
Revenue increased 19.2% for the full year due to claims review and analysis services, among others, while operating profit declined 3.5% due to higher costs for medium- to long-term growth, including the addition of ケーシップ. - FY2025-H1Revenue growth, but lower profit due to strategic investmentAnnual report
「The main factor was revenue growth driven by strong performance in the claims review service, insurer operations support service, and cloud-based claims management service for public assistance, among others. However, profit declined due to higher personnel expenses and strategic investment, among other costs, aimed at medium- to long-term growth, including the addition of 株式会社ケーシップ to this business from the current consolidated fiscal year.」
The healthcare big data business delivered 23.5% revenue growth on strong performance in claims review, insurer operations support, and cloud services for public assistance, while operating profit declined 25.6% due to the addition of ケーシップ and higher personnel expenses and strategic investment. - FY2024-Q3AdvancedAnnual report
「Revenue was ¥1,557 million, up 31.4% year on year, and operating profit was ¥285 million, up 66.7% year on year. The main factor was revenue growth in high-margin businesses such as analysis services and data utilization services.」
High-margin businesses such as analysis services and data utilization services increased revenue, resulting in revenue growth of 31.4% and operating profit growth of 66.7%. - FY2024-Q2AdvancedAnnual report
「Revenue was ¥917 million, up 27.6% year on year, and operating profit was ¥103 million, up 46.6% year on year. The main factor was revenue growth in high-margin businesses such as analysis services and data utilization services.」
High-margin businesses such as analysis services and data utilization services increased revenue, resulting in revenue growth of 27.6% and operating profit growth of 46.6%. - FY2024-Q1AdvancedAnnual report
「Revenue was ¥415 million, up 30.0% year on year, and operating profit was ¥15 million, up 52.0% year on year. The main factor was revenue growth in high-margin businesses such as analysis services and data utilization services.」
High-margin businesses such as analysis services and data utilization services increased revenue, resulting in 30.0% revenue growth and 52.0% operating profit growth in the healthcare big data business. - FY2023AdvancedAnnual report
「Revenue was ¥2,021 million, up 11.9% year on year, and operating profit was ¥457 million, up 19.9% year on year. The main factor was an improvement in the profitability of the business as a whole due to the expansion of high-margin businesses such as analysis services and insurer operations support services.」
High-margin businesses such as analysis services and insurer operations support services expanded, resulting in revenue growth of 11.9% and operating profit growth of 19.9%. - FY2023-Q3Revenue growth, narrower profit decline, but profitability remains an issueAnnual report
「Revenue was ¥1,185 million, up 4.2% year on year, and operating profit was ¥171 million, down 18.8% year on year. The main factor was that, although orders for the business as a whole remained steady, the timing of revenue recognition for high-margin businesses such as analysis services was concentrated in the same period of the previous year. Compared with the plan for the business, results as of the end of the third quarter continued to progress ahead of schedule, and the business is understood to have remained steady during the period.」
Orders in the healthcare big data business remained steady, and revenue increased 4.2% year on year. However, operating profit declined 18.8% due to the impact of the concentration of revenue recognition for high-margin businesses such as analysis services in the same period of the previous year. The company explained that progress was ahead of plan. - FY2023-Q2WorsenedAnnual report
「Revenue was ¥718 million, down 2.9% year on year, and operating profit was ¥70 million, down 45.8% year on year. The main factor was that, although orders for the business as a whole remained steady, the timing of revenue recognition for high-margin businesses such as analysis services was concentrated in the same period of the previous year.」
Although orders in the healthcare big data business remained steady, revenue declined 2.9% and operating profit declined 45.8% due to the reversal of the concentration of revenue recognition for high-margin businesses such as analysis services in the same period of the previous year. - FY2023-Q1WorsenedAnnual report
「Revenue was ¥319 million, down 10.9% year on year, and operating profit was ¥10 million, down 79.5% year on year. The main factor was that, although the insurer operations support service exceeded the previous year, revenue declined in high-margin businesses such as analysis services.」
While the insurer operations support service exceeded the previous year, revenue declined in high-margin businesses such as analysis services, resulting in lower revenue and profit in the healthcare big data business. - FY2022AdvancedAnnual report
「In this business, the automated claims review service, which had been somewhat weak in the same period of the previous year due to a decline in medical institution users associated with the spread of COVID-19, entered a recovery trend in the current period. In addition, the expansion of high-margin businesses such as analysis and notification services and insurer operations support services improved the profitability of the business as a whole. As a result, revenue was ¥1,806 million, up 27.2% year on year, and operating profit was ¥245 million, up 170.0% year on year.」
In addition to the recovery of the automated claims review service, high-margin businesses such as analysis and notification services and insurer operations support expanded. Revenue increased 27.2% year on year, operating profit increased 170.0%, and an improvement in profitability across the business was confirmed for the full year as well. - FY2022-Q3AdvancedAnnual report
「In this business, the automated claims review service, which had been somewhat weak in the same period of the previous year due to a decline in medical institution users associated with the spread of COVID-19, entered a recovery trend from the current period onward. In addition, improvements in high-margin businesses such as analysis and notification services, the cloud-based claims management service for public assistance and other programs, and insurer operations support services improved the profitability of the business as a whole. Furthermore, various service-related projects in progress for which revenue had previously been recognized upon customer acceptance began to be recognized based on the progress toward satisfying performance obligations under the Accounting Standard for Revenue Recognition, which took effect from the current period. As a result, revenue was ¥1,137 million, up 37.4% year on year, and operating profit was ¥107 million, compared with an operating loss of ¥39 million in the same period of the previous year.」
In addition to the recovery of the automated claims review service, high-margin businesses such as analysis and notification services, the cloud-based claims management service for public assistance and other programs, and insurer operations support improved. Revenue increased 37.4% year on year, and operating results turned from a loss of ¥39 million to a profit of ¥107 million. - FY2022-Q2AdvancedAnnual report
「In this business, the automated claims review service, which had been somewhat weak in the same period of the previous year due to a decline in medical institution users associated with the spread of COVID-19, entered a recovery trend from the current period onward. In addition, improvements in high-margin businesses such as analysis and notification services, the cloud-based claims management service for public assistance and other programs, and insurer operations support services improved the profitability of the business as a whole. Furthermore, various service-related projects in progress for which revenue had previously been recognized upon customer acceptance began to be recognized based on the progress toward satisfying performance obligations under the Accounting Standard for Revenue Recognition, which took effect from the current period. As a result, revenue was ¥740 million, up 38.6% year on year, and operating profit was ¥61 million, compared with an operating loss of ¥36 million in the same period of the previous year.」
The automated claims review service entered a recovery trend, while high-margin businesses such as analysis and notification services, the cloud-based claims management service for public assistance and other programs, and insurer operations support also improved. Revenue increased 38.6% year on year, and operating results turned from a loss of ¥36 million to a profit of ¥61 million. - FY2022-Q1AdvancedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), although the insurer operations support service was below the previous year, revenue increased in the analysis and medical expense notification service and the automated claims review service, among others. Revenue was ¥358 million, up 49.2% year on year, and operating profit was ¥9 million, compared with an operating loss of ¥54 million in the same period of the previous year.」
Due to revenue growth in the analysis and medical expense notification service and the automated claims review service, revenue increased 49.2% year on year, and operating results turned from a loss of ¥54 million to a profit of ¥9 million. - FY2021Revenue growth and profit decline due to changes in the service mixAnnual report
「Although the automated claims review service and the medical expense notification service were below the previous year, revenue increased in the insurer operations support service and the cloud-based claims management service for public assistance and other programs. Revenue remained steady, but due to increased research and development investment and other factors, revenue was ¥1,419 million, up 8.0% year on year, and operating profit was ¥90 million, down 3.0% year on year.」
The drivers of revenue growth broadened from the previous focus on automated claims review and medical expense notification services to insurer operations support and cloud services for public assistance. However, due to increased research and development investment and other factors, operating profit declined 3.0% year on year. - FY2021-Q3RestatedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), support services for insurers and other services exceeded the previous year and revenue remained steady. However, due to higher costs including research and development expenses, revenue was ¥827 million, up 8.5% year on year, and the operating loss was ¥39 million, compared with an operating loss of ¥26 million in the same period of the previous year.」
While the expansion of support services for insurers and other services and revenue growth continued, the operating loss widened from ¥26 million in the same period of the previous year to ¥39 million due to higher costs including research and development expenses. - FY2021-Q2RestatedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), support services for insurers and other services exceeded the previous year and revenue remained steady. However, due to higher costs including research and development expenses, revenue was ¥534 million, up 8.4% year on year, and the operating loss was ¥36 million, compared with an operating loss of ¥23 million in the same period of the previous year.」
Support services for insurers and other services exceeded the previous year, and the rollout of healthcare big data-related services continued. However, due to higher costs including research and development expenses, the operating loss widened from ¥23 million in the same period of the previous year to ¥36 million. - FY2021-Q1RestatedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), support services for insurers and other services exceeded the previous year and revenue remained steady. However, due to higher costs including research and development expenses, revenue was ¥240 million, up 23.3% year on year, and the operating loss was ¥54 million, compared with an operating loss of ¥53 million in the same period of the previous year.」
Support services for insurers and other services exceeded the previous year, and revenue increased 23.3% year on year. However, due to higher costs including research and development expenses, the operating loss was ¥54 million, with the loss level nearly unchanged from the same period of the previous year. - FY2020AdvancedAnnual report
「In the healthcare big data business (review and analysis of medical information data and related services), the automated claims review service and the medical expense notification service, among others, performed steadily, resulting in revenue of ¥1,313 million, up 34.3% year on year, and operating profit of ¥93 million, compared with an operating loss of ¥95 million in the previous fiscal year.」
Revenue in the healthcare big data business increased 34.3% year on year, and operating results also turned from a loss of ¥95 million to a profit of ¥93 million. - FY2020-Q3AdvancedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), the automated claims review service and the analysis and medical expense notification service performed steadily, resulting in revenue of ¥763 million, up 25.6% year on year, and an operating loss of ¥26 million, compared with an operating loss of ¥126 million in the same period of the previous year.」
The automated claims review service and the analysis and medical expense notification service performed steadily. Revenue increased 25.6% year on year, while the operating loss narrowed from ¥126 million to ¥26 million. - FY2020-Q2AdvancedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), the automated claims review service and the analysis and medical expense notification service performed steadily, resulting in revenue of ¥492 million, up 28.8% year on year, and an operating loss of ¥23 million, compared with an operating loss of ¥103 million in the same period of the previous year.」
The automated claims review service and the analysis and medical expense notification service performed steadily. Revenue increased 28.8% year on year, while the operating loss narrowed from ¥103 million to ¥23 million. - FY2020-Q1AdvancedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), the automated claims review and analysis services performed steadily, resulting in revenue of ¥194 million, up 9.3% year on year, and an operating loss of ¥53 million, compared with an operating loss of ¥65 million in the same period of the previous year.」
The automated claims review and analysis services performed steadily. Revenue increased 9.3% year on year, while the operating loss narrowed from ¥65 million to ¥53 million. - FY2019RestatedAnnual report
「In the healthcare big data business (review and analysis of medical information data and related services), the automated claims review service and the medical expense notification service performed steadily. However, with costs such as organizational expansion increasing ahead of revenue growth, revenue was ¥977 million, up 0.3% year on year, and the operating loss was ¥95 million, compared with an operating loss of ¥12 million in the previous fiscal year.」
The steady performance of the automated claims review service and the medical expense notification service continued to be noted, while total business revenue increased only 0.3% year on year. - FY2019-Q3RestatedAnnual report
「Lastly, in the healthcare big data business (review and analysis of medical information data and related services), the automated claims review service and the analysis and medical expense notification service performed steadily. However, with costs such as organizational expansion increasing ahead of revenue growth, revenue was ¥607 million, up 5.0% year on year, and the operating loss was ¥126 million, compared with an operating loss of ¥58 million in the same period of the previous year.」
The automated claims review service and the analysis and medical expense notification service continued to perform steadily. However, as costs such as organizational expansion increased ahead of revenue growth, revenue increased 5.0% year on year, while the operating loss widened from ¥58 million to ¥126 million. - FY2019-Q2RestatedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), the automated claims inspection service and analytical and medical expense notification services performed solidly. However, costs associated with strengthening the organization and other measures preceded the increase in revenue, resulting in revenue of ¥382 million, up 1.6% year on year, and an operating loss of ¥103 million, compared with an operating loss of ¥36 million in the same period of the previous year.」
The steady performance of the automated claims review service and the analysis and medical expense notification service continued to be noted. Revenue increased 1.6% year on year. - FY2019-Q1RestatedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), the automated claims inspection service and analytical and medical expense notification services performed solidly. However, costs associated with strengthening the organization and other measures preceded the increase in revenue, resulting in revenue of ¥178 million, up 8.2% year on year, and an operating loss of ¥65 million, compared with an operating loss of ¥29 million in the same period of the previous year.」
The automated claims inspection service and analytical and medical expense notification services performed solidly, confirming the continued development of medical big data-related services. - FY2018-Q3RestatedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), adoption of the claims management cloud service for local governments remained firm, resulting in revenue of ¥578 million, up 14.7% year on year, and an operating loss of ¥58 million, compared with an operating loss of ¥64 million in the same period of the previous year.」
Adoption of the claims management cloud service for local governments continued to remain firm. Revenue increased 14.7% year on year, while the operating loss narrowed from ¥64 million to ¥58 million. - FY2018-Q2AdvancedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), adoption of the claims management cloud service for local governments remained firm, resulting in revenue of ¥376 million, up 12.9% year on year, and an operating loss of ¥36 million, compared with an operating loss of ¥43 million in the same period of the previous year.」
Adoption of the claims management cloud service for local governments remained firm. Revenue increased 12.9% year on year, while the operating loss narrowed from ¥43 million to ¥36 million. - FY2018-Q1AdvancedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), adoption of the claims management cloud service for local governments remained firm, resulting in revenue of ¥164 million, up 4.7% year on year, and an operating loss of ¥29 million, compared with an operating loss of ¥32 million in the same period of the previous year.」
Progress in the adoption of the claims management cloud service for local governments was specifically reported. Revenue increased 4.7% year on year, while the operating loss narrowed from ¥32 million to ¥29 million. - FY2017RestatedAnnual report
「Revenue remained firm as services were expanded beyond the automated claims inspection service to include cloud services for inspection providers, analytical and medical expense notification services, data health plan support services and others, but」
The continued expansion of medical big data-related services was reported, with revenue of ¥774 million, up 32.5% from the previous consolidated fiscal year. - FY2017-Q3RestatedAnnual report
「Finally, in the medical big data business (inspection and analysis of medical information data and related services), revenue remained firm as services were expanded beyond the automated claims inspection service to include cloud services for inspection providers, analytical and medical expense notification services, data health plan support services and others. However, costs associated with strengthening the organization in anticipation of future growth preceded the increase in revenue, resulting in revenue of ¥504 million, up 35.6% year on year, and an operating loss of ¥64 million, compared with an operating loss of ¥48 million in the same period of the previous year.」
The continued expansion of services including automated claims inspection, cloud services, analytical and medical expense notification services, and data health plan support was reported, with revenue up 35.6% year on year. - FY2017-Q2RestatedAnnual report
「Revenue remained firm as services were expanded beyond the automated claims inspection service to include cloud services for inspection providers, analytical and medical expense notification services, data health plan support services and others, but」
The continued expansion of medical big data-related services was reported, with revenue of ¥333 million, up 43.2% year on year. - FY2017-Q1First statedAnnual report
「Revenue remained firm as services were expanded beyond the automated claims inspection service to include analytical and medical expense notification services, cloud services for inspection providers, data health plan support services and others, but」
In addition to its existing services, the company is offering multiple analysis, cloud and data health-related services.